Investors ready to resuscitate Johnson & Johnson's ailing stock

NEW YORK (Reuters) - Johnson & Johnson shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock's relatively cheap valuation may be set to apply a Band-Aid to the declines.

from Reuters: Business News https://ift.tt/2JIzJoV